Showing results (131-140 of 157) with videos related to

Sort By:
Pageof 16
BMC Medicine|September 11, 2023
Maternal multimorbidity and preterm birth in Scotland: an observational record-linkage studyAmaya Azcoaga-Lorenzo, Adeniyi Francis Fagbamigbe, Utkarsh Agrawal, et al.
Health Technology Assessment (Winchester, England)|October 13, 2016
Treatments for hyperemesis gravidarum and nausea and vomiting in pregnancy: a systematic review and economic assessmentAmy O'Donnell, Catherine McParlin, Stephen C Robson, et al.
Frontline Gastroenterology|April 29, 2021
Standards for the provision of antenatal care for patients with inflammatory bowel disease: guidance endorsed by the British Society of Gastroenterology and the British Maternal and Fetal Medicine SocietyChristian Selinger, Nicola Carey, Shelley Cassere, et al.
JAMA|October 5, 2016
Treatments for Hyperemesis Gravidarum and Nausea and Vomiting in Pregnancy: A Systematic ReviewCatherine McParlin, Amy O'Donnell, Stephen C Robson, et al.
BMJ Open Respiratory Research|June 30, 2018
British Thoracic Society Guideline for the initial outpatient management of pulmonary embolismLuke S Howard, Steven Barden, Robin Condliffe, et al.
BMJ Open|January 16, 2021
A patient-clinician James Lind Alliance partnership to identify research priorities for hyperemesis gravidarumCaitlin R Dean, Hyke Bierma, Ria Clarke, et al.
BMC Pregnancy and Childbirth|August 1, 2023
Key outcomes for reporting in studies of pregnant women with multiple long-term conditions: a qualitative studySiang Ing Lee, Stephanie Hanley, Zoe Vowles, et al.
Trials|September 12, 2023
A treatment strategy with nifedipine versus labetalol for women with pregnancy hypertension: study protocol for a randomised controlled trial (Giant PANDA)Danielle Ashworth, Cheryl Battersby, Debra Bick, et al.
Health Technology Assessment (Winchester, England)|November 16, 2021
Ondansetron and metoclopramide as second-line antiemetics in women with nausea and vomiting in pregnancy: the EMPOWER pilot factorial RCTStephen Robson, Catherine McParlin, Helen Mossop, et al.
The Lancet. Rheumatology|June 14, 2024
The time of equipoise on the use of biological DMARDs in for inflammatory arthritis during pregnancy is finally over: a reappraisal of evidence to optimise pregnancy managementIan Giles, Iona Thorne, Nanna Surlemont Schmidt, et al.
Pageof 16